INSM
Insmed Incorporated
NASDAQ · USHealthcareBiotechnology
$107.02-1.20%
Price as of Jul 20, 2026
INSM valuation
Insmed Incorporated valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 145.91x
- P/E 2028E
- 27.50x
- P/S forward
- 11.22x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 32.91x
- Price / sales
- 28.30x
- Price / cash flow
- -25.90x
Enterprise value
- Enterprise value
- $22.7B
- EV / sales
- 27.72x
- EV / EBITDA
- -21.01x
- EV / EBIT
- -20.13x
- Market cap
- $23.2B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.